Structural and functional kidney abnormalities in patients with Human immunodeficiency virus infection: A cross-sectional perspective

Table 1 General characteristics of the study population, n (%)

Parameter	Frequency (n = 227)
Age (year), mean ± SD	41 ± 9.3
Gender
Male	76 (33.5)
Female	151 (66.5)
BMI
< 25 kg/m2	74 (32.6)
≥ 25 kg/m2	153 (67.4)
Duration of HIV infection (year), mean ± SD	5 ± 1.3
Duration of ART regimen (year), mean ± SD	4.18 ± 1.2
WHO stage of HIV infection
Stage 1	39 (17.2)
Stage 2	68 (30)
Stage 3	95 (41.9)
Stage 4	25 (11)
CD4 count
< 200 cells/mm3	81 (35.7)
≥ 200 cells/mm3	146 (64.3)
ART regimen
Tenofovir based	177 (78)
Non-tenofovir based	50 (22)
eGFR
< 60	124 (54.6)
≥ 60	103 (45.4)

BMI: Body mass index; HIV: Human immunodeficiency virus; ART: Anti-retroviral therapy; CD: Cluster differentiation; WHO: World Health Organization; eGFR: Estimated glomerular filtration rate.